Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04569773 · ClinicalTrials.gov registry record
Choosing Ovarian Preservation or Removal Before Surgery for Endometrial Cancer
A clinical trial of Endometrial Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 43
- Enrollment target
- 8
- Study locations
NCT04569773 is a study of Endometrial Cancer that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 43 participants, below the 524-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (92% lower). The trial reports 8 study locations across 3 states.
The verdict
NCT04569773, a study of Endometrial Cancer, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 43 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of this study is to learn more about the factors that influence decision-making before surgery (distress about cancer and/or reproductive concerns) and the possibility of regret after surgery.
Conditions Studied
Interventions
- BEHAVIORAL Impact of Event Scale-Revised
- BEHAVIORAL Reproductive Concerns Scale
- BEHAVIORAL Decision Regret Scale
Study Locations (8)
New York
- Memorial Sloan Kettering Cancer Center @ Suffolk (All protocol activities) - Commack
- Memorial Sloan Kettering Westchester (All protocol activities) - Harrison
- Memorial Sloan Kettering Cancer Center (All Study Activities) - New York
- Memorial Sloan Kettering Nassau (All protocol activities) - Rockville Centre
New Jersey
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities) - Basking Ridge
- Memorial Sloan Kettering Monmouth (All protocol activities) - Middletown
- Memorial Sloan Kettering Bergen (All protocol activities) - Montvale
Connecticut
- Hartford Healthcare (Data Collection) - Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2020-09-23 |
| Est. Completion | 2026-09-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04569773
The ClinicalTrials.gov registry entry for NCT04569773 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 524-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (92% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Endometrial Cancer appearing as the primary indexed condition, and to 3 interventions - of which Impact of Event Scale-Revised is the first listed.
NCT04569773 reports 8 study locations spanning 3 distinct geographic areas - top geographies include New York, New Jersey, Connecticut.
Frequently Asked Questions
What is clinical trial NCT04569773 about?
NCT04569773 is a clinical study titled "Choosing Ovarian Preservation or Removal Before Surgery for Endometrial Cancer". The purpose of this study is to learn more about the factors that influence decision-making before surgery (distress about cancer and/or reproductive concerns) and the possibility of regret after surgery.
What is the current status of trial NCT04569773?
This trial is currently active not recruiting. The enrollment target is 43 participants. The study started on 2020-09-23. Estimated completion is 2026-09-23.
What conditions does trial NCT04569773 study?
This clinical trial studies the following conditions: Endometrial Cancer.
What interventions are being tested in trial NCT04569773?
The interventions under investigation include: Impact of Event Scale-Revised (BEHAVIORAL), Reproductive Concerns Scale (BEHAVIORAL), Decision Regret Scale (BEHAVIORAL).
Who is sponsoring clinical trial NCT04569773?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04569773 being conducted?
This trial has 8 study locations across Connecticut, New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometrial Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
RECRUITING · Phase 1
-
The Better, Harder, Faster, Stronger Study
RECRUITING
-
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RECRUITING · Phase 1
-
Study of AVZO-021 in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
RECRUITING · Phase 1
-
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.